TRANSGENE (EPA:TNG) | Finanzwire

Basculer en Français

10793	Companies
233179	Keywords
161777	Articles
124386	Press releases

Home
Companies
TRANSGENE

PRESS RELEASE

published on 04/13/2026 at 08:00, 3 months 19 days ago

Transgene Completes Patient Randomization in Phase 2 Part of Clinical Trial Evaluating TG4050 in the Adjuvant Treatment of Head and Neck Cancer
Transgene completes patient randomization in Phase 2 of clinical trial for TG4050 in adjuvant treatment of head and neck cancer. Top-line results expected by Q1 2028

Clinical Trial Head And Neck Cancer Phase 2 Transgene TG4050
BRIEF

published on 04/02/2026 at 17:50, 4 months ago

Transgene and NEC Bio Forge Partnership for TG4050 Development

License Agreement Transgene Neoantigen Vaccine NEC Bio TG4050 Development
PRESS RELEASE

published on 04/02/2026 at 17:45, 4 months ago

Transgene and NEC Bio Sign License Agreement to Prepare the Next Steps of the Development of TG4050 in Head and Neck Cancer
Transgene and NEC Bio sign license agreement to advance development of TG4050 in head and neck cancer, leveraging AI technology for neoantigen selection

AI Technology Head And Neck Cancer Transgene TG4050 NEC Bio
BRIEF

published on 03/26/2026 at 17:50, 4 months 7 days ago

Transgene to Present TG4050 Vaccine Data at World Vaccine Congress

World Vaccine Congress Cancer Immunotherapy Transgene TG4050 Neoantigen Vaccine
PRESS RELEASE

published on 03/26/2026 at 17:45, 4 months 7 days ago

Transgene to Deliver an Oral Presentation on its Individualized Neoantigen Therapeutic Vaccine TG4050 at the World Vaccine Congress
Transgene to present oral session on TG4050, an Individualized Neoantigen Therapeutic Vaccine, at World Vaccine Congress. Phase 1 findings in head and neck cancer and potential in early-stage treatment to be discussed

World Vaccine Congress Vaccine Transgene TG4050 Individualized Neoantigen
BRIEF

published on 01/23/2026 at 08:05, 6 months 10 days ago

Transgene strengthens its scientific committee with two immunotherapy experts.

Immunotherapy Cancer Transgene Antoine Italiano Ignacio Melero
BRIEF

published on 01/23/2026 at 08:05, 6 months 10 days ago

Transgene Enhances Scientific Advisory Board with New Appointments

Scientific Advisory Board Cancer Immunotherapy Transgene Antoine Italiano Ignacio Melero
PRESS RELEASE

published on 01/23/2026 at 08:00, 6 months 10 days ago

Transgene Further Strengthens Scientific Advisory Board with Appointments of Renowned Cancer Immunotherapy Experts Antoine Italiano and Ignacio Melero
Transgene strengthens Scientific Advisory Board with renowned cancer immunotherapy experts Prof. Antoine Italiano and Prof. Ignacio Melero. Appointment to accelerate development of myvac® platform and viral vector-based cancer vaccines

Scientific Advisory Board Cancer Immunotherapy Transgene Antoine Italiano Ignacio Melero
BRIEF

published on 11/27/2025 at 00:20, 8 months 5 days ago

Transgene: Resumption of Trading on Euronext Paris

Euronext Paris Biotechnology Capital Increase Transgene Quoting
PRESS RELEASE

published on 11/27/2025 at 00:15, 8 months 5 days ago

Transgene announces the resume of trading of its shares on Euronext Paris as of the opening of the markets
Transgene resumes trading of shares on Euronext Paris following capital increase results publication

Euronext Paris Shares Trading Capital Increase Transgene

Accesswire

Published on 08/01/2026 at 01:20, 1 day 22 hours ago

Gamma Resources Announces $880,000 Private Placement with Full Warrant Coverage
Published on 08/01/2026 at 01:15, 1 day 22 hours ago

Clean Air Metals and Fiore-Backed Springbok Ventures Announce Strategic Business Combination
Published on 08/01/2026 at 00:30, 1 day 22 hours ago

Battery X Metals Announces Amendment to Corporate Awareness Engagement
Published on 08/01/2026 at 00:25, 1 day 22 hours ago

BioNxt Solutions Announces Option Grants
Published on 07/31/2026 at 23:20, 2 days ago

Pentagon I Capital Corp. Announces Conditional Acceptance of Qualifying Transaction with Prospectiva Resources Ltd.

View all ACCESSWIRE

EQS Group

Published on 08/02/2026 at 08:15, 15 hours 5 minutes ago

Holcim signs agreement to divest its business in the Philippines
Published on 08/01/2026 at 16:35, 1 day 6 hours ago

HIZENERGY Enters Global Top Tier with BloombergNEF Tier 1 Listing
Published on 07/31/2026 at 19:55, 2 days 3 hours ago

EQS-Adhoc: ABO Energy GmbH & Co. KGaA Reaches Agreement with Financing Partners on Extension of Standstill Agreement and Continuation of Restructuring Process
Published on 07/31/2026 at 19:05, 2 days 4 hours ago

Eurobattery Minerals presents the Q2 report for 2026 as the Company accelerates the development of the San Juan tungsten project
Published on 07/31/2026 at 18:55, 2 days 4 hours ago

Holding(s) in Company

Les Echos

Published on 07/31/2026 at 21:00, 2 days 2 hours ago

Carrefour completes the sale of its minority stake in CarrefourSA in Turkey to Yeni Mağazacılık A.Ş., operator of the A101 retail chain and controlled by the Aydın Group
Published on 07/31/2026 at 19:27, 2 days 3 hours ago

Share retention commitments (Dutreil Agreement)
Published on 07/31/2026 at 19:14, 2 days 4 hours ago

2026 First-Half financial report
Published on 07/31/2026 at 19:13, 2 days 4 hours ago

Covivio - Information on Treasury shares transactions between July 29th, 2026 and July 31st, 2026
Published on 07/31/2026 at 18:30, 2 days 4 hours ago

Covivio Hotels - 2026 Half-year financial report

View all LES ECHOS COMFI WIRE